<DOC>
	<DOCNO>NCT01124058</DOCNO>
	<brief_summary>A prospective , randomized trial compare time take achieve therapeutic INR upon re-starting warfarin `` loading '' dose ( namely 1.5 time `` maintenance '' dose 3 day ) compare know `` maintenance '' dose .</brief_summary>
	<brief_title>Evaluation Maintenance Dosing v Loading Dosing Upon Restarting Warfarin Therapy : A Prospective Randomized Trial</brief_title>
	<detailed_description>Patients identify via University Alberta Hospital Anticoagulation Management Service . Following receipt write , informed consent , patient randomize re-start warfarin `` maintenance '' dose `` load '' dose ( 1.5 time maintenance dose 3 day , resumption warfarin dose per maintenance dose ) . Randomization perform on-line EPICORE Centre . Assuming Day 1 day warfarin re-started , patient INRs do day 3 least every 2 day thereafter therapeutic INR obtain . In addition , protein C , protein S factor II level obtain patient stable maintenance dose warfarin ( i.e. , prior hold warfarin procedure ) , 7 day re-starting warfarin , 14 day re-starting warfarin . Complete blood count ( CBCs ) do INR patient take low molecular weight heparin ( LMWH ) . Patients anticoagulant therapy manage AMS 6 week receive telephone follow-up AMS 90 day determine bleed clot complication occur .</detailed_description>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Have 'stable warfarin maintenance dose ' ( define last 2 INRs within therapeutic range weekly warfarin dose change 10 % ) Have INR indicative take warfarin ( INR &lt; 1.4 ) confirmation patient take warfarin past 4 day Provide write , inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>restart warfarin</keyword>
	<keyword>time therapeutic INR</keyword>
</DOC>